Abdul Mannan Explains How DOACs Can Confuse Lupus Anticoagulant Testing
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, has shared a post on LinkedIn:
“Late on a Friday, Dr. Jones reviewed a DRVVT:
• Screen: prolonged
• Mix: no correction
• Confirm: completely normalised
With a confident grin, he declared: ‘Classic Lupus Anticoagulant.’
Diagnosis: Antiphospholipid Syndrome.
Actually, the patient was on rivaroxaban.
The apparent ‘LA’ was nothing more than a DOAC in disguise, and the confirm reagent just happened to mask the culprit.
Moral of the story
Before calling ‘Eureka!’ in the coagulation lab, always check for anticoagulants. DOACs can mimic lupus anticoagulant and mislead even the most confident interpretation.
Learning point
Pre-analytical details are not small print. They are often the hidden plot twists in coagulation testing.”
For more information, check here.
Don’t miss the latest updates with Hemostasis Today.
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week